The effect of certain tranquilisers, chlorpromazine metabolites and diethyldithiocarbamate on tissue amphetamine levels in the rat.
D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects; D001570:Benzodiazepinones / Q000494:pharmacology; D001921:Brain / Q000378:metabolism; D002746:Chlorpromazine / Q000378:metabolism*; D003913:Dextroamphetamine / Q000378:metabolism*; D003975:Diazepam / Q000494:pharmacology; D006207:Half-Life; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007668:Kidney / Q000378:metabolism; D008099:Liver / Q000378:metabolism; D008297:Male; D010087:Oxides / Q000378:metabolism; D010546:Perphenazine / Q000494:pharmacology; D010640:Phenothiazines / Q000494:pharmacology; D051381:Rats; D013239:Stereotyped Behavior / Q000187:drug effects; D013859:Thiocarbamates / Q000494:pharmacology*; D013997:Time Factors; D014149:Tranquilizing Agents / Q000494:pharmacology*; D014268:Trifluoperazine / Q000494:pharmacology; D014316:Tritium
D001570:Benzodiazepinones; D010087:Oxides; D010640:Phenothiazines; D013859:Thiocarbamates; D014149:Tranquilizing Agents; D014316:Tritium; D014268:Trifluoperazine; D010546:Perphenazine; D003975:Diazepam; D003913:Dextroamphetamine; D002746:Chlorpromazine